IP Library Granted Patent US 8,445,611
Granted Patent B2
US 8,445,611 · App. 13/441,114 · Granted May 21, 2013

Antimicrobial polymers

Inventors: Gregory N. Tew (South Deerfield, MA); Ahmad E. Madkour (Leverett, MA); Karen Lienkamp (Ware, MA); Ashlan Marie Musante (Mainz, DE)
Assignee: University of Massachusetts
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,445,611
App. No.
13/441,114
Granted
May 21, 2013
Kind
B2
Abstract

The invention generally relates to novel polymers (SMAMPs) and their syntheses and use. The polymers exhibit promising properties of AMPs. In particularly, for example, a ring-opening metathesis polymerization (ROMP) platform was developed that allows syntheses of SMAMPs that employ a minimum number of norbornene-based building blocks and/or enable easy and independent variation of hydrophobic and hydrophilic groups in the monomer units and/or along the polymeric backbone to finetune and select desirable properties of the polymers.

Claims (24)

1. A method for reducing or eliminating bacterial microorganisms comprising treating an object with a composition comprising an antimicrobial effective amount of a polymer, wherein the polymer comprises a monomer unit having the structure of:

wherein one of R 1 and R 2 comprises a hydrophobic group and the other one of R 1 and R 2 comprises a hydrophilic group; and X is C═R 3 , O or S, wherein R 3 is a C 1 -C 12 alkyl or alkoxy group.

2. The method of claim 1 , wherein the hydrophobic group comprises a substituted or unsubstituted alkyl group.

3. The method of claim 1 , wherein the hydrophilic group comprises a group selected from ammonium ions, sulfonium ions, guanidinium ions, phosphonium ions, and mono- and di-alkyl substituted amino groups.

4. The method of claim 1 , wherein the hydrophilic group is a guanidinium ion.

5. The method of claim 1 , wherein X is O; R 1 is a linear or branched C 1 -C 12 alkyl group; and R 2 is

or a guanidinium ion, wherein p is an integer from about 1 to about 10.

6. The method of claim 1 , wherein both —C(═O)O— groups in (II) occupy the exo-stereo position.

7. The method of claim 5 , wherein R 1 is a linear or branched C 1 -C 6 alkyl group; and p is an integer from about 1 to about 5.

8. The method of claim 1 , wherein X is C═R 3 ; R 1 is a linear or branched C 1 -C 12 alkyl group; R 2 is

or a guanidinium ion, wherein p is an integer from 1-10.

9. The method of claim 8 , wherein R 3 is a C 1 -C 12 alkyl.

10. The method of claim 1 , wherein n is an integer from about 1 to about 1,000.

11. The method of claim 1 , wherein the polymer is a co-polymer.

12. The method of claim 11 , wherein the co-polymer comprises the structural monomer units of:

wherein

each of X′ and X″ is C═R 3 , O or S, wherein R 3 is a C 1 -C 12 alkyl or alkoxy group;

each of R 1 ′ and R 1 ″ is a hydrophobic group and each of R 2 ′ and R 2 ″ is a hydrophilic group, provided that R 1 ′ and R 1 ″ are not the same, R 2 ′ and R 2 ″ are the same, or X′ and X″ are not the same; and

each of m and n is an integer from about 1 to about 1,000.

13. The method of claim 12 , wherein the hydrophilic group comprises a group selected from ammonium ions, sulfonium ions, guanidinium ions, phosphonium ions, and mono- and di-alkyl substituted amino groups.

14. The method of claim 12 , wherein all —C(═O)O— groups in (III) and (IV) occupy the exo-stereo position.

15. The method of claim 12 , wherein

each of R 1 ′ and R 1 ″ is independently a linear or branched C 1 -C 12 alkyl group; and each of R 2 ′ and R 2 ″ is independently

or a guanidinium ion, wherein p is an integer from 1-10.

Assignments (1)
INTELLECTUAL PROPERTY SECURITY AGREEMENT RELATING TO PATENTS LICENSED BY POLYMEDIX PHARMACEUTICALS, INC. OR POLYMEDIX, INC. Recorded Jan 17, 2013
From: POLYMEDIX, INC.; POLYMEDIX PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL SBIC, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 029660/0282 →
Continuity (3)
Continuation 12795892 · Jun 8, 2010
Provisional Application 61185035 · Jun 8, 2009
Related Publication 20120195849A1 · Aug 2, 2012